zepbound tirzepatide eli lilly to sell directly to consumers without insurance coverage Lilly launches lower-price weight-loss drug

An ad airing Super Bowl Sunday features Americas deadliest epidemic, obesity, and what can be done about it with the use of affordable compounded weight loss drugs.

The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists represents one of the most significant advances in obesity and diabetes treatment in recent

The proportion of participants agreeing/strongly agreeing with statements indicating the presence of food noise decreased from 4763% before semaglutide to 1520% after

With a strong foothold in emerging markets and a potential 10x market growth, Ajanta aims to become a leading player in the global GLP-1 market by 2027.

The Gila monster's venom contains a peptide that scientists adapted into modern GLP-1 medications